The Q4 decline did not change the annual net profit situation of Quartz shares soared, and the “red envelopes” of 2 billion yuan had an impressive dividend rate | Financial Report Interpretation

① Driven by rapidly growing demand in downstream photovoltaics, semiconductor and other industries, Quartz's net profit in 2023 increased 3.78 times year-on-year. ② The company also introduced a high dividend and transfer plan that pays a cash dividend of 57 yuan for every 10 shares and increases 5 shares for every 10 shares. ③ The company's 2023 cash dividend per share reached 7 yuan. Currently, the dividend ratio is 8.43%, ranking third among all A-shares.

cls.cnMar 23 00:08

Production and sales of photovoltaic materials are booming, semiconductor certification accelerates the annual net profit pre-increase of up to 4 times for Quartz

① Quartz shares expect net profit of 4.75 billion yuan to 5.33 billion yuan in 2023, an increase of 351.44%-406.56% over the previous year. ② Due to high demand for photovoltaics and resource bottlenecks, high-purity quartz sand is in short supply. Prices continued to rise last year, but this year they have declined slightly. ③ Quartz Co., Ltd. has just started in the semiconductor market, but it continues to pass certification from international semiconductor equipment vendors and is increasing production capacity.

cls.cnJan 23 22:22

Dabeinong performs “I ate and vomit” and Aonong Biotech went from a “sweet marriage” to a “peaceful break up”

① Due to major changes such as equity freezes in Aonong Biotech's controlling shareholder Aonong, the equity cooperation between Dabinong Biotech and Aonong Biotech was terminated; ② Since December, Aonong Biotech has issued announcements relating to the controlling shareholder's share pledge on three days. The controlling shareholder's pledge ratio has continued to rise. Currently, the pledge ratio is close to 98%;

cls.cnDec 26, 2023 19:50

The debt ratio is as high as 89%, Wu Youlin, the actual controller of Aonong Biotech, wants to sell big assets to “ask” the old owner Dabeinong to take over?

① Dabeinong plans to obtain no less than 51% of Aonong's investment through capital increases and stock expansion, and Aonong Biotech's actual controller may change; ② Aonong Biotech's balance ratio is as high as 89.41%, of which short-term loans are about 4.51 billion yuan, and total current liabilities are about 11.55 billion yuan, while the monetary capital on the account is only less than 300 million yuan.

cls.cnDec 12, 2023 23:18

Has Dabeinong's acquisition of Jiuding Technology come to an end? In the second trial, the Hunan High Court upheld the original judgment again

① The second trial of Dabeinong's acquisition of Jiuding Technology ushered in a judgment. The Hunan High Court rejected the appeal and upheld the original judgment ② In the third quarter report, Dabeinong has initiated plans for the acquisition of shares in Jiuding Technology and Zhengbang Technology

cls.cnDec 1, 2023 09:26

The world's leading fund added Hong Kong stocks in Q3. How can it seize the market with smart money?

The new heavy stock holdings were mainly focused on education and hardware; software and photovoltaics were transferred out.

中金點睛Nov 28, 2023 09:44